Targeted therapy for ROS1-positive NSCLC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Targeted therapy for ROS1-positive NSCLC, covering 2024-11-19 to 2024-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC